As demand surges for virtual GI care, Oshi Health—America’s first nationwide virtual gastroenterology center of excellence—has named Brittany Flanagan as its first Chief People Officer. Formerly with Amazon Pharmacy and PillPack, Flanagan brings deep expertise in scaling mission-driven healthcare organizations and will lead efforts to expand Oshi’s workforce while preserving its award-winning culture.
Author: Abhay Panchal
Just as law enforcement has its “Blue Wall,” medicine harbors its own—what Dr. Sachin Jain calls the “White Wall of Silence.” In this powerful Forbes commentary, he argues that unchecked loyalty among physicians too often shields bad actors, enabling incompetence, overuse, and even harm to persist in silence.
Retail giants like Amazon, Walgreens, and Best Buy stormed into healthcare with bold promises—only to find the system far more complex than expected. As reported by Modern Healthcare and analyzed by Advisory Board, efforts to scale clinical care have hit hard walls: rising costs, reimbursement hurdles, and the unforgiving pace of quarterly earnings. Some, like Walmart, have already bowed out. Others remain, but the question is no longer if they can disrupt healthcare—it’s whether they can do it patiently and profitably, over years, not quarters.
As newer noninvasive screening tools flood the market, the fecal immunochemical test (FIT) continues to hold its ground—quietly, effectively, and with patient-friendly convenience. In this Medscape commentary, Dr. Kenny Lin revisits the data behind FIT, including results from a major European trial showing no significant difference in colorectal cancer deaths between FIT and colonoscopy over a 10-year span. But FIT’s continued relevance depends on one critical factor: patient follow-through. Can small changes—like using liquid vials, tweaking instructions, or adding a deadline—make a big difference in adherence? Evidence says yes.
In this podcast episode, Ryan Stidham, MD, discusses the evolution and development of digital imaging and AI in the GI space, how AI can revolutionize stages within the clinical trials and practices and more.
EndoQuest Robotics has officially launched its pivotal PARADIGM clinical trial with the successful completion of its first two robotic endoscopic submucosal dissection (ESD) procedures. Performed by renowned colorectal surgeon Dr. Eric Haas, the trial is testing EndoQuest’s groundbreaking Endoluminal Surgical (ELS) System—a flexible, single-use robotic platform designed for scar-free, natural orifice surgery. If proven effective, the system could transform how complex colorectal lesions are treated, making minimally invasive options more accessible. But as the U.S. remains slow to adopt ESD due to technical challenges, the real question looms: can robotics finally tip the scale?
A quiet revolution in GI care may be underway. At DDW 2025, researchers presented findings suggesting that advanced practice providers (APPs) can safely and effectively perform transnasal endoscopies (TNE) using single-use devices—without sedation. The pilot study showed not only strong technical success and patient tolerance, but also real-world impact: care plans changed for 92% of patients. As systems face bottlenecks and GI access challenges, could trained APPs become the key to expanding upper GI diagnostics? Early results are promising—but experts caution that wide-scale adoption will hinge on rigorous training, payer acceptance, and cultural shift.
Women—especially in midlife—are facing a silent GI epidemic. While functional and serious GI conditions surge, the average wait time for specialist care in the U.S. stretches to 48 days. For many women, that delay is not just inconvenient—it’s devastating. In this powerful piece, Sheri Rudberg of WovenX Health lays bare the systemic failures women encounter: misdiagnosis, dismissal, and care pathways not designed with them in mind. Drawing from personal stories and a call to redesign virtual GI care, the article urges stakeholders to rethink how, when, and for whom care is delivered.
From Fast Company: What if the future of healthcare depends on the kids no one’s looking at?Health tech is transforming lives—helping people with Parkinson’s drink coffee without trembling, catching cancer early, and restoring simple daily joys. But Fast Company spotlights a growing challenge: a looming global shortage of tech and healthcare workers that could stall this life-changing progress. At the same time, millions of young people from low-income communities remain an untapped resource. Medtronic believes the answer lies in bridging this gap—not just through degrees, but by expanding access to hands-on STEM education, skills-based hiring, and visibility into careers students…
Dr. Neil Parikh, Chief Innovation Officer at Connecticut GI and Chair of the GI Alliance Innovation Committee, brings a refreshingly grounded perspective to the future of gastroenterology. For him, innovation isn’t research—it’s real-world feasibility. It’s pilot programs born from pain points like access, cost, and patient satisfaction. And it’s about using the scale and clinical volume of independent practices to drive meaningful change—shaping not just care delivery, but potentially the guidelines themselves. In this candid conversation, Dr. Parikh maps out where GI is headed: AI-powered triage and documentation, actionable microbiome data, non-invasive diagnostics, and the quiet revolution of food and…